Projects per year
Personal profile
Biography
Peter Donnan is Professor of Epidemiology and Biostatistics in the Medical School Division of Population Health and Genomics within the Medical Research Institute, University of Dundee. He has 35 years’ experience in the design and analysis of Health Services and Population Research observational studies as well as randomised controlled trials of drugs (steroids in Bell’s Palsy, NEJM, 2007) as well as public health interventions (screening for breast cancer, The Lancet, 1990, Football Fans In Training, The Lancet, 2014) and informatics (eSMART, BMJ 2021 and DQIP, NEJM 2016).
He leads the Dundee Epidemiology and Biostatistics Unit (DEBU) and co-leads the Tayside Clinical Trials Unit (TCTU) which has UKCRC registration and successfully manages approximately 20 clinical trials. He has also carried out extensive population record-linkage research on drug safety, adherence and management of long term conditions using Tayside’s and Scotland’s unique prescribing population databases and is the author of over 250 publications (h-index 60, m-index 1.42), as well as an investigator on research projects to a total of over £35 million.
He has developed a number of prognostic algorithms, most notably predicting Coronary Heart Disease (CHD) in people with type 2 diabetes (Diabetes Care, 2006), and Chief Scientist Office funded algorithm to predict risk of emergency admissions in primary care (PEONY) with a view to developing cost-effective interventions for long term conditions (Archives Internal Medicine, 2008). An NIHR HTA-funded study has developed aids to clinical decision making with abnormal liver function tests in primary care. He is senior author of a study to predict outcomes for those admitted to hospital with Acute Pancreatitis using health informatics across Scotland.
He has supervised 25 PhD and MSc students and externally examined PhD theses across the UK. He has developed Master’s level modules in clinical trials and provides a record linkage analysis module for the Dundee MPH (15 students) as well as the Scottish-wide Precision Medicine and Pharmacological Innovation MSc (35 students).
In 2004, Prof. Donnan was invited to become a member of the New Drugs Committee of the Scottish Medicines Consortium which seeks to advise Area and Drug Therapeutics Committees across Scotland regarding the cost-effectiveness of new drugs and continues in this work with expertise in indirect comparisons, missing data and survival analysis in trials.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Network
-
The iDiabetes Platform - Enhanced Phenotyping of Patients With Diabetes For Precision Diagnosis, Prognosis and Treatment (Joint with NHS Education for Scotland and University of Aberdeen)
Bell, S., Croudace, T., Cunningham, S., Dillon, J., Doney, A., Donnan, P., Farre, A., Lang, C., McCrimmon, R., Mordi, I., Palmer, C. & Pearson, E.
1/05/22 → 30/04/26
Project: Research
-
Early Cancer Detection Test (CDT) Lung Screening Programme
Donnan, P., Fardon, T., McCowan, C., Schembri, S., Sullivan, F. & Treweek, S.
1/06/12 → 30/09/25
Project: Research
-
COVID-19 In Care-Homes In Tayside And Fife (Joint with NHS Tayside, University of Edinburgh and University of Gllasgow)
Donnan, P., Fletcher, E., Marwick, C. & Parcell, B.
1/05/21 → 31/10/21
Project: Research
-
Derivation and validation of the CFracture competing risk fracture prediction tool compared with QFracture in older people and people with comorbidity: a population cohort study
Livingstone, S. J., Guthrie, B., McMinn, M., Eke, C., Donnan, P. T. & Morales, D. R., Jan 2023, In: The Lancet. Healthy longevity. 4, 1, p. e43-e53 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)10 Downloads (Pure) -
Free-text analysis of general practice out-of-hours (GPOOH) use by people with advanced cancer: an analysis of coded and uncoded free-text data
Mills, S. E. E., Brown-Kerr, A., Buchanan, D., Donnan, P. T. & Smith, B. H., Feb 2023, In: British Journal of General Practice. 73, 727, p. e124-e132 9 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Downloads (Pure) -
A pre-operative prognostic model predicting all cause and cause specific mortality for women presenting with invasive breast cancer
Wang, H., Donnan, P., Macaskill, E. J., Jordan, L., Thompson, A. & Evans, A., Feb 2022, In: Breast. 61, p. 11-21 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile36 Downloads (Pure) -
Clinical improvement of DM1 patients reflected by reversal of disease-induced gene expression in blood
van Cruchten, R. T. P., van As, D., Glennon, J. C., van Engelen, B. G. M. & ‘t Hoen, P. A. C., 2022, In: BMC Medicine. 20, 1, 17 p., 395.Research output: Contribution to journal › Article › peer-review
Open AccessFile24 Downloads (Pure) -
Community prescribing trends and prevalence in the last year of life, for people who die from cancer
Mills, S. E. E., Buchanan, D., Donnan, P. T. & Smith, B. H., 8 Jul 2022, In: BMC Palliative Care. 21, 13 p., 120.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)14 Downloads (Pure)
Activities
- 1 Membership of group
-
Scottish Medicines Consortium (External organisation)
Peter Donnan (Member)
2014Activity: Membership types › Membership of group